Mahesh Karande - Feb 1, 2022 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
President and CEO, Director
Signature
/s/ Barbara Chan as Attorney-in-Fact for Mahesh Karande
Stock symbol
OMGA
Transactions as of
Feb 1, 2022
Transactions value $
$5,989
Form type
4
Date filed
2/3/2022, 03:05 PM
Previous filing
Jul 29, 2021
Next filing
Mar 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMGA Common Stock Options Exercise $5.99K +11.3K +10.62% $0.53* 118K Feb 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Option (Right to Buy) Options Exercise $0 -11.3K -1.26% $0.00 884K Feb 1, 2022 Common Stock 11.3K $0.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable with respect to 25% of the underlying shares on April 1, 2020 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on April 1, 2023, subject to the Reporting Person's continued service to the Issuer through each vesting date.